The OAC is pleased to share that Novo Nordisk, a long-time supporter of OAC, has renewed their support of the organization on OAC’s Chairman’s Council at the Platinum level. Thank you, Novo Nordisk, for continuing to support and champion our mission!
More About Novo Nordisk
Novo Nordisk is a leading global healthcare company that’s been making innovative medicines to help people with diabetes lead longer, healthier lives for nearly 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity and rare blood and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially, and environmentally responsible way. With U.S. headquarters in New Jersey and production and research facilities in seven states, Novo Nordisk employs nearly 6,000 people throughout the country. For more information, visit novonordisk.us.
OAC Chairman’s Council
The OAC is grateful to have the Platinum-level support of Novo Nordisk through our Chairman’s Council as we strive to partner with industry leaders who share in our mission of supporting people with obesity through education and advocacy.
We welcome ANY individual, organization or company who wishes to join the highest level of OAC Membership and receive maximum benefits. OAC’s Chairman’s Council is an excellent way to give back to our cause and play an integral role in making the world a better place for people with obesity.
To learn more about OAC’s Chairman’s Council, click here.